Purchasing for high-quality care using National Health Insurance: evidence from Zambia.


Journal

Health policy and planning
ISSN: 1460-2237
Titre abrégé: Health Policy Plan
Pays: England
ID NLM: 8610614

Informations de publication

Date de publication:
16 Jun 2023
Historique:
received: 30 08 2022
revised: 04 03 2023
accepted: 04 04 2023
medline: 19 6 2023
pubmed: 7 4 2023
entrez: 6 4 2023
Statut: ppublish

Résumé

Improving the quality of care is essential for progress towards universal health coverage. Health financing arrangements offer opportunities for governments to incentivize and reward improvements in the quality of care provided. This study examines the extent to which the purchasing arrangements established within Zambia's new National Health Insurance can improve equitable access to high-quality care. We adopt the Strategic Purchasing Progress and the Lancet Commission for High-Quality Health Systems frameworks to critically examine the broader health system and the purchasing dimensions of this insurance scheme and its implications for quality care. We reviewed policy documents and conducted 31 key-informant interviews with stakeholders at national, subnational and health facility levels. We find that the new health insurance could boost financial resources in higher levels of care, improve access to high-cost interventions, improve care experiences for its beneficiaries and integrate the public and private sectors. Our findings also suggest that health insurance will likely improve some aspects of structural quality but may not be able to influence process and outcome measures of quality. It is also not clear if health insurance will improve the efficiency of service delivery and whether the benefits realized will be distributed equitably. These potential limitations are attributable to the existing governance and financial challenges, low investments in primary care and shortcomings in the design and implementation of the purchasing arrangements of health insurance. Although Zambia has made progress in a short span, there is a need to improve its provider payment mechanisms, and monitoring and accounting for a higher quality of care.

Identifiants

pubmed: 37022137
pii: 7109858
doi: 10.1093/heapol/czad022
pmc: PMC10274566
doi:

Types de publication

Review Journal Article

Langues

eng

Pagination

681-688

Subventions

Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
ID : CRSII5_183577

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine.

Références

Health Syst (Basingstoke). 2019 Mar 1;9(4):317-325
pubmed: 33354323
PLoS One. 2021 Mar 2;16(3):e0247397
pubmed: 33651816
Health Syst Reform. 2022 Mar 1;8(2):e2051796
pubmed: 35446229
Int J Health Plann Manage. 2018 Oct;33(4):1159-1177
pubmed: 30074642
Pharmacoecon Open. 2019 Dec;3(4):517-526
pubmed: 30859490
PLoS Med. 2014 Sep 22;11(9):e1001730
pubmed: 25243780
BMJ Glob Health. 2020 Sep;5(9):
pubmed: 32999053
Lancet. 2018 Nov 17;392(10160):2203-2212
pubmed: 30195398
Lancet Glob Health. 2018 Nov;6(11):e1196-e1252
pubmed: 30196093
QRB Qual Rev Bull. 1990 Dec;16(12):424-38
pubmed: 2101446
Health Syst Reform. 2022 Mar 1;8(2):e2058337
pubmed: 35695801
Health Syst Reform. 2021 Jan 1;7(1):e1898186
pubmed: 33914676
Health Syst Reform. 2018;4(4):313-323
pubmed: 30395765
Int J Equity Health. 2021 Feb 26;20(1):66
pubmed: 33637090
Lancet. 2012 Sep 8;380(9845):933-43
pubmed: 22959390
BMC Health Serv Res. 2010 Aug 23;10:247
pubmed: 20731816
Bull World Health Organ. 2013 Aug 1;91(8):602-11
pubmed: 23940408
BMC Health Serv Res. 2021 Oct 6;21(1):1057
pubmed: 34610823

Auteurs

Doris Osei Afriyie (D)

Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Kreuzstrasse 2, Allschwil 4123, Switzerland.
University of Basel, Petersplatz 1, Basel 4001, Switzerland.

Felix Masiye (F)

Department of Economics, University of Zambia, Lusaka, Zambia.

Fabrizio Tediosi (F)

Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Kreuzstrasse 2, Allschwil 4123, Switzerland.
University of Basel, Petersplatz 1, Basel 4001, Switzerland.

Günther Fink (G)

Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Kreuzstrasse 2, Allschwil 4123, Switzerland.
University of Basel, Petersplatz 1, Basel 4001, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH